This is primarily achieved through reducing PD-L1 expression and adjusting the populations of infiltrating immune cells like TAMs, MDSCs, Treg, CD8+ T cells, and CAFs within the tumor (Fig. 3b). This evidence concerns the gene CD274 and neoplasm.